Keyphrases
Parkinson's Disease
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
61%
Parkinson Patients
24%
Patients with Parkinson's Disease
22%
Mutation Carriers
20%
G2019S mutation
18%
Ashkenazi Jews
18%
Non-carriers
18%
LRRK2 mutation
15%
Non-manifesting Carriers
15%
Idiopathic Parkinson's Disease
11%
Parkinson's Disease Risk
10%
LRRK2 Gene
9%
G2019S
9%
Healthy Controls
9%
GBA mutations
9%
Functional Magnetic Resonance Imaging
9%
GBA Gene
7%
Unified Parkinson's Disease Rating Scale (UPDRS)
7%
First-degree Relatives
7%
Early Parkinson's Disease
6%
Disease Phenotype
6%
Executive Function
6%
Disease-related
5%
Genotype
5%
Ashkenazi
5%
Genetic Testing
5%
Dementia with Lewy Bodies
5%
Creutzfeldt-Jakob Disease
5%
Disease Severity
5%
Motor Symptoms
5%
Neuroscience
Parkinson's Disease
93%
Leucine Rich Repeat Kinase 2
16%
Glucosylceramidase
9%
Functional Magnetic Resonance Imaging
8%
Magnetic Resonance Imaging
5%
Functional Connectivity
5%
Stereotypic Movement Disorder
5%
Executive Function
5%
Dementia with Lewy Bodies
5%
